News
-
-
-
COMMUNIQUÉ DE PRESSE
Formycon sets Benchmark in Biosimilar Development: Scientific Foundation of the innovative Development Program for FYB206 published in the Journal BioDrugs
Formycon sets a benchmark in biosimilar development with the publication of the scientific foundation of the innovative development program for FYB206 in the Journal BioDrugs -
-
-
COMMUNIQUÉ DE PRESSE
Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year
Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year. Successful clinical development enhances Formycon's position in biosimilars -
-
-
-
